BiotechTube
Innovo Therapeutics

Innovo Therapeutics

Cambridge, United States· Est.
innovotherapeutics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $30M

Overview

Innovo Therapeutics is a private, preclinical-stage biotech leveraging an AI/ML-driven platform for small molecule drug discovery in oncology and inflammation. Headquartered in the biotech hub of Cambridge, the company is in an early, formative stage, as evidenced by its 'website coming soon' status and limited public information. Its strategy focuses on identifying novel targets and compounds for significant unmet medical needs, positioning it within the competitive but high-potential AI-driven drug discovery landscape.

OncologyInflammatory Diseases

Technology Platform

AI and machine learning platform for small molecule drug discovery and design.

Funding History

2
Total raised:$30M
Series A$25M
Seed$5M

Opportunities

Operates in large, high-value therapeutic markets (oncology, inflammation) with persistent unmet need.
The application of AI/ML offers a potential paradigm shift to improve the speed and success rate of early drug discovery, attracting significant investor and partner interest.

Risk Factors

High technical risk that the AI platform may not yield clinically viable drug candidates.
Financial risk as a pre-revenue company dependent on external funding.
Intense competition in the AI drug discovery space from both startups and established pharmaceutical companies.

Competitive Landscape

The AI/ML drug discovery sector is highly competitive, featuring numerous well-funded startups (e.g., Recursion, Exscientia, Insilico Medicine) and major investments from large pharma. Innovo must differentiate through novel algorithms, proprietary data, or unique therapeutic insights to secure a sustainable position.

More companies in AI / Machine Learning →More companies in United States →